G-FED

This brand name is authorized in Nigeria.

Active ingredients

The drug G-FED contains a combination of these active pharmaceutical ingredients (APIs):

1	Pseudoephedrine UNII 6V9V2RYJ8N - PSEUDOEPHEDRINE HYDROCHLORIDE
	Pseudoephedrine is a sympathomimetic agent with direct and indirect effects on adrenergic receptors. It has alpha and beta adrenergic activity and some stimulant effect on the central nervous system. The sympathomimetic effect of pseudoephedrine produces vasoconstriction which in turn relieves nasal congestion.
	Read more about Pseudoephedrine
2	Triprolidine UNII 2L8T9S52QM - TRIPROLIDINE

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-1070	Tablet	G-Fed Tablets TAB 60 mg; 2.5 mg 24 x 4's (in PVC-Alu blister)	Uncoated Tablet 102 RNW-PP-311019 G-FED TABLETS TRIPOLODINE 2.5MG & PSEDOEPHEDRINE HYDROCHLORIDE 60MG TRIPOLIDINE 2.5MG BP PSEUDOEPHEDRINE HCL BP 60MG, MICROCRYSTALLINE CELLULOSE POWDER BP, COLLOIDAL ANHYDROUS SILICA BP, MAIZE STARCH BP, SODIUM STARCH GLYCOLATE BP, POVIDONE K 30 BP, ISOPROPYL ALCOHOL BP, PURIFIED TALC BP, MAGNESIUM STEARATE BP A4-1070 Drugs Imported Products 24X4 OTC 2/3/2023 GREENLIFE PHARMACEUTICALS LIMITED, 35A, ASSOCIATION AVENUE, ILUPEJU, LAGOS 17378995 greenlife.regulatory@yahoo.com OSAKA PHARMACEUTICALS PVT LTD, OLD NATIONAL HIGHWAY NO. 8, SANKARDA 391 350, DISTRICT, VADODARA, GUJARAT, INDIA, India	06/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R01BA52	Pseudoephedrine, combinations	R Respiratory system → R01 Nasal preparations → R01B Nasal decongestants for systemic use → R01BA Sympathomimetics
Discover more medicines within R01BA52

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-1070